Larvol Delta - CNS-Pharmaceuticals-Inc-Featured-in-Syndicated-Broadcast-Covering-Activation-of-First-Clinical-Trial-Sites-in-Europe-Evaluating-Berubicin-for-the-Treatment-of-GBM

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://www.globenewswire.com/news-release/2022/10/07/2530232/0/en/CNS-Pharmaceuticals-Inc-Featured-in-Syndicated-Broadcast-Covering-Activation-of-First-Clinical-Trial-Sites-in-Europe-Evaluating-Berubicin-for-the-Treatment-of-GBM.html

Oct 7, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next